Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03298243 · ClinicalTrials.gov registry record · NA

Use of Sensory Substitution to Improve Arm Control After Stroke

A NA study of Stroke and Proprioceptive Disorders, sponsored by Marquette University.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT03298243 is a NA study of Stroke and Proprioceptive Disorders that is actively recruiting participants, run by Marquette University. The registered enrollment target is 30 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03298243, a NA study of Stroke and Proprioceptive Disorders, is actively recruiting participants, sponsored by Marquette University.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Supplementing or augmenting sensory information to those who have lost proprioception after stroke could help improve functional control of the arm. Thirty subjects will be recruited to a single site to evaluate the ability of supplemental kinesthetic feedback (a form of vibrotactile stimulation) to improve motor function. Participants will be tested in performing reaching movements as well as more functional tasks such as simulated drinking from a glass

Interventions

  • BEHAVIORAL Vibrotactile stimulation

Study Locations (1)

Wisconsin

  • Marquette University - Milwaukee

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-07-17
Est. Completion 2026-05-31
Phase NA

Sponsor

Marquette University

27 total trials

What the Registry Record Tells You About NCT03298243

The ClinicalTrials.gov registry entry for NCT03298243 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Marquette University, which has 27 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Vibrotactile stimulation is the first listed.

NCT03298243 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT03298243 about?

NCT03298243 is a clinical study titled "Use of Sensory Substitution to Improve Arm Control After Stroke". Supplementing or augmenting sensory information to those who have lost proprioception after stroke could help improve functional control of the arm. Thirty subjects will be recruited to a single site to evaluate the ability of supplemental kinesthetic feedback (a form of vibrotactile stimulation) to...

What is the current status of trial NCT03298243?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-07-17. Estimated completion is 2026-05-31.

What conditions does trial NCT03298243 study?

This clinical trial studies the following conditions: Stroke, Proprioceptive Disorders.

What interventions are being tested in trial NCT03298243?

The interventions under investigation include: Vibrotactile stimulation (BEHAVIORAL).

Who is sponsoring clinical trial NCT03298243?

This trial is sponsored by Marquette University, which has 27 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03298243 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.